Advertisement
Advertisement
CCCC
C4 Therapeutics, Inc.
4.35
USDSponsored
+0.10
+2.45%
Jun 25, 10:08 UTC -4
Open
CCCC Earnings Reports
Positive Surprise Ratio
CCCC beat 15 of 23 last estimates.
65%
Next Report
Date of Next Report
Aug 05, 2026
Estimate for Q2 26 (Revenue/ EPS)
$4.08M
/-$0.23
Implied change from Q1 26 (Revenue/ EPS)
-33.68%
/+15.00%
Implied change from Q2 25 (Revenue/ EPS)
-36.87%
/-37.84%
C4 Therapeutics, Inc. earnings per share and revenue
On May 12, 2026, CCCC reported earnings of -0.20 USD per share (EPS) for Q1 26, beating the estimate of -0.37 USD, resulting in a 47.29% surprise. Revenue reached 6.15 million, compared to an expected 3.40 million, with a 80.94% difference. The market reacted with a 0.00% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 6 analysts forecast an EPS of -0.23 USD, with revenue projected to reach 4.08 million USD, implying an increase of 15.00% EPS, and decrease of -33.68% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
enGene Therapeutics Inc. Common Stock
Report Date
Jun 15, 2026 For Q2 26
Estimate
-$0.47
Actual
-$0.43
Surprise
+10.32%
Grace Therapeutics, Inc. Common Stock
Report Date
Jun 18, 2026 For Q4 26
Estimate
-$0.23
Actual
-$0.06
Surprise
+74.42%
Vistagen Therapeutics, Inc. Common Stock
Report Date
Jun 15, 2026 For Q4 26
Estimate
-$0.34
Actual
-$0.37
Surprise
-7.75%
FAQ
What were C4 Therapeutics, Inc.'s earnings and revenue for the latest quarter Q1 2026?
For Q1 2026, C4 Therapeutics, Inc. reported EPS of -$0.20, beating estimates by 47.29%, and revenue of $6.15M, 80.94% above expectations.
How did the market react to C4 Therapeutics, Inc.'s Q1 2026 earnings?
The stock price moved -- 0%, changed from $3.17 before the earnings release to $3.17 the day after.
When is C4 Therapeutics, Inc. expected to report next?
The next earning report is scheduled for Aug 05, 2026.
What are the forecasts for C4 Therapeutics, Inc.'s next earnings report?
Based on 6
analysts, C4 Therapeutics, Inc. is expected to report EPS of -$0.23 and revenue of $4.08M for Q2 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement